In pharmacokinetic theory, a compound reaches approximately 97% of its steady-state plasma concentration after five consecutive half-life periods
It was first isolated from human plasma in 1973 by Dr
Therapeutic Research Protocol Dose: 300 600 mcg (1 2 capsules) Duration: 6 10 weeks Frequency: Once daily, preferably before physical-activity windows Cycle Interval: 3 4 weeks off before repeating Goal / Description: Used in research targeting endurance, fat oxidation, and ERR pathway activation
These findings were not attributed to variations in food intake, which implies that the observed results were mediated by alterations in metabolic processes [1]
Whether its through injections, shots under the skin, or IV, the aim is the same
This could be due to a number of reasons: Dr